BioCentury
ARTICLE | Financial News

BioTime completes warrant exercise

August 30, 2010 7:00 AM UTC

BioTime Inc. (NYSE-A:BTIM), Alameda, Calif. Business: Hematology, Gene/Cell therapy Date completed: 8/19/10 Type: Warrant exercise Raised: $9.2 million Shares: 5.1 million Price: $1.82 Shares after of...